Arctoris Logo

Arctoris Risk Report

Generated on July 17, 2025

1

Risks

Summary

πŸ“œ Innovation & R&D

Arctoris has demonstrated a consistent focus on innovation and collaborative research to advance drug discovery. They have formed strategic partnerships with other tech and pharma companies to enhance their research capabilities. Notably, these collaborations often aim to leverage cutting-edge technologies like AI and robotics to accelerate drug discovery processes.

  • On πŸ—“ September 13, 2021, Arctoris partnered with IBM Research to use AI and cloud technology for closed-loop drug discovery, improving efficiency in their research operations.
  • Arctoris celebrated its 5th anniversary by launching an expanded robotic platform, Ulysses, on πŸ—“ February 24, 2021. This development underscores their commitment to enhancing research capabilities through automation.
  • Their partnership with Insilico Medicine announced on πŸ—“ July 9, 2020, focused on discovering new COVID-19 drugs, demonstrating agility in addressing urgent public health challenges.

πŸ‘₯ Labor & Workforce

Arctoris has been strategically expanding its workforce, as highlighted by recent efforts to build a robust executive team. This growth reflects the company's continued expansion and its commitment to sustaining operational excellence through a strong leadership foundation.

  • Following significant growth, Arctoris announced the expansion of its executive team on πŸ—“ August 26, 2024, indicative of its need for enhanced leadership to manage its increasing operations.

πŸ—οΈ Operational & Business Continuity

There have been key operational advancements by Arctoris, which ensure its business continuity and respond to evolving market demands. The acquisition of strategic assets and partnerships with other companies have been pivotal to maintaining operational resilience.

  • Arctoris acquired Eli Lilly's Life Sciences Studio Lab, moving an automation platform from San Diego to Oxford, on πŸ—“ September 13, 2024. This move is strategic in bolstering their operational capability in critical locations.

πŸ… Awards & Recognition

Arctoris has been recognized within the industry as a leading entity in the field of cloud robotics, furthering its reputation as a forward-thinking and innovative company.

  • Arctoris was identified as one of the top 10 cloud robotics start-ups on πŸ—“ July 22, 2021, underscoring its position as a pioneering force in integrating robotics with research activities.

News & Media

Stay informed with real-time news signals across financial, legal, and operational domains.

Profile

Founded Year
2016
Social Media
Specialties
AI, Biotech, IND, PROTACs, antibodies, automation, biochemistry, cell biology, drug development, drug discovery, fundamental research, hit ID, hit-to-lead, lead optimization, machine learning, molecular biology, novel therapeutics, robotics, small molecule, target validation